Skip to main navigation menu Skip to main content Skip to site footer

Research Article

Vol. 2 No. 2 (1996)

ACE Genotype Distributions Differ between Sporadic and Familial Hypertrophic Cardiomyopathy

  • Ara Kassarjian, B.S.
  • Eleanor Elstein, M.D., F.R.C.P. (C)
DOI
https://doi.org/10.26443/mjm.v2i2.746
Submitted
November 12, 2020
Published
2020-12-01

Abstract

This study investigated the frequency of ACE genotypes in sporadic hypertrophic cardiomyopathy (HCM) and compared these frequencies to those found in the general population and in familial HCM. Delineation of the genotype of a 287 bp fragment in the ACE gene of 10 patients with confirmed sporadic HCM demonstrated that 2 (20%) were of the DD genotype, 5 (50%) of the ID genotype, and 3 (30%) of the II genotype. These genotype distributions did not differ significantly from controls (p < 0.57). Comparison of the present results with genotype frequencies in familial HCM reported in prior studies revealed a significant difference in genotype distribution between sporadic and familial HCM (p < 0.04). These findings indicate that the frequency of the ACE genotype does not appear to differ between patients with sporadic HCM and the general population. However, the results suggest that, with regard to the ACE polymorphism studied, genetic differences may exist between the sporadic and familial forms of HCM.

References

  1. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin angiotensin system. Annual Review of Physiology 54: 227-41; 1992.
  2. Soubrier F, Alhenc-Gelas F, Hubert C, et al. Two putative active centers in human angiotensin I converting enzyme revealed by molecular cloning. Proceedings of the National Academy of Sciences of the United States of America 85(24): 9386-90; 1988.
  3. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation 86(4): 1343-46; 1990.
  4. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxy-peptidase 1). Nucleic Acids Research 20(6): 1433; 1992.
  5. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359(6396): 641-44; 1992.
  6. Tiret L, Kee F, Poirier O, et al. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341(8851): 991-2; 1993.
  7. Raynolds MV, Bristow MR, Bush EW, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342(8879): 1073-75; 1993.
  8. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme and left ventricular hypertrophy. New England Journal of Medicine 360(23): 1634-8; 1994.
  9. Beohar N, Damaraju S, Prather A, et al. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. Journal of Investigative Medicine 43(3): 275-80; 1995.
  10. Marian AJ, Yu QT, Workman R, et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342(8879): 1085-6; 1993.
  11. Lechin M, Quinones MA, Omran A, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 92(7): 1808-12; 1995.
  12. Leadon SA, Cerutti PA. A rapid and mild procedure for the isolation of DNA from mammalian cells. Analytical Biochemistry 120(2): 282-8; 1982.
  13. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods & Applications 3(2): 120-1; 1993.
  14. Perna NT, Batzer MA, Deininger PL, et al. Alu insertion polymorphism: a new type of marker for human population studies. Human Biology 64(5): 641-8; 1992.

Downloads

Download data is not yet available.